PGI23 Cost Effectiveness of Retreatment of Patients with Chronic Hepatitis C (Chc) Who Do Not Respond to Peginterferon Alpha and Ribavirin for 48 Weeks Vs. Peginterferon Alfa and Ribavirin for 72 Weeks

Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.750
https://www.valueinhealthjournal.com/article/S1098-3015(12)00815-7/fulltext
Title : PGI23 Cost Effectiveness of Retreatment of Patients with Chronic Hepatitis C (Chc) Who Do Not Respond to Peginterferon Alpha and Ribavirin for 48 Weeks Vs. Peginterferon Alfa and Ribavirin for 72 Weeks
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00815-7&doi=10.1016/j.jval.2012.03.750
First page : A139
Section Title : Gastrointestinal Disorders
Open access? : No
Section Order : 228
Categories :
Tags :
Regions :
ViH Article Tags :